Eczema treatment for hands
Pro Research Analysisby 
Searched over 200M research papers
Hand Eczema Treatment: Topical Corticosteroids and Emollients
Topical corticosteroids are widely recognized as the first-line treatment for hand eczema, especially for mild to moderate cases. They help reduce inflammation and control symptoms, but should not be used continuously for more than 6–8 weeks without medical supervision due to potential side effects like skin thinning Lund2017Ho2023Elsner2019+2 MORE. Emollients (moisturizing creams) are also essential for daily skin care, helping to restore the skin barrier and prevent flare-ups Ho2023Lee2019Saeki2024+1 MORE.
Second-Line and Adjunctive Therapies: Calcineurin Inhibitors and Phototherapy
For patients who do not respond to topical corticosteroids, topical calcineurin inhibitors such as tacrolimus and pimecrolimus may be considered, although the evidence for their effectiveness is limited Lund2017Christoffers2002Elsner2019. Phototherapy, including PUVA (psoralen plus UVA) and narrow-band UVB, is effective for moderate to severe hand eczema, but can be time-consuming and may cause side effects like skin redness Lund2017Ho2023Elsner2019+1 MORE. Both PUVA and UVB have shown improvement in hand eczema severity, with PUVA being the traditional option and UVB offering a shorter treatment time .
Systemic Treatments: Alitretinoin, Cyclosporine, and Emerging Options
Systemic therapy is reserved for severe or chronic hand eczema that does not respond to topical treatments. Alitretinoin is the only approved oral medication specifically for severe chronic hand eczema and has shown to be more effective than placebo in controlling symptoms, though it may cause headaches at higher doses Lund2017Ho2023Christoffers2002+3 MORE. Cyclosporine is another systemic option, particularly for severe, relapsing cases, and has demonstrated effectiveness similar to alitretinoin Christoffers2002Elsner2019Cheng2022. Other systemic agents, such as acitretin and azathioprine, are used off-label and require careful monitoring Christoffers2002Brass2018.
New and Emerging Therapies: Biologics and JAK Inhibitors
Recent advances in hand eczema treatment include biologics like dupilumab (an IL-4/IL-13 inhibitor) and topical or oral Janus kinase (JAK) inhibitors such as delgocitinib and ruxolitinib. These targeted therapies are showing promise in clinical trials, offering improved efficacy and safety profiles compared to traditional treatments Lee2019Christoffers2002Brass2018+1 MORE. As research continues, these new drugs may become important options for patients with difficult-to-treat hand eczema.
Patient Education and Prevention
Education on avoiding triggers (such as irritants and allergens) and consistent use of skin care routines are crucial components of hand eczema management. Identifying the underlying cause through diagnostic measures like allergy testing can help tailor treatment and prevent recurrences Lund2017Ho2023Saeki2024.
Conclusion
Hand eczema treatment typically starts with topical corticosteroids and emollients, progressing to calcineurin inhibitors, phototherapy, or systemic agents like alitretinoin and cyclosporine for more severe cases. New therapies, including biologics and JAK inhibitors, are emerging and may offer additional options in the future. Patient education and preventive strategies remain essential for long-term management and improved quality of life Lund2017Ho2023Lee2019+7 MORE.
Sources and full results
Most relevant research papers on this topic